Christopher Missling is Chief Executive Officer of Anavex Life Sciences Corp. (AVXL). The company reported total compensation of $3,959,085 for fiscal year 2025.
| Salary | $723,485 |
|---|---|
| Bonus | $140,000 |
| Stock awards | $0 |
| Option awards | $3,083,000 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $12,600 |
| Total | $3,959,085 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Anavex Life Sciences Corp. filed August 11, 2026, accession 0001731122-26-001038.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $723,485 | $140,000 | $0 | $3,083,000 | $0 | $0 | $12,600 | $3,959,085 |
| FY2024 | President, Chief Executive Officer and Director | $700,000 | $140,000 | $0 | $1,927,600 | $0 | $0 | $16,100 | $2,783,700 |
Totals as disclosed in each year's own compensation disclosure for Anavex Life Sciences Corp..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Missling this page | Chief Executive Officer | $3,959,085 |
| Sandra Boenisch | Principal Financial Officer | $555,270 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Anavex Life Sciences Corp. compensation brief.
Christopher Missling's compensation sits inside Anavex Life Sciences Corp.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.